Detalles de la búsqueda
1.
A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy.
Int J Cancer
; 139(1): 177-86, 2016 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26891420
2.
Russian Consensus on Exo- and Endocrine Pancreatic Insufficiency After Surgical Treatment.
Turk J Gastroenterol
; 32(3): 225-239, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34160352
Resultados
1 -
2
de 2
1
Próxima >
>>